Covid-19 roundup: Gilead aims remde­sivir to­ward help­ing In­dia out­break; Mer­ck pairs with 5 In­di­an gener­ics man­u­fac­tur­ers for mol­nupi­ravir

As the num­ber of Covid-19 cas­es in In­dia dra­mat­i­cal­ly in­creas­es, Gilead will do­nate 450,000 vials of its remde­sivir drug to the gov­ern­ment.

The com­pa­ny …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.